These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 34228117)

  • 1. APOE ε4 Association With Cognition and Alzheimer Disease Biomarkers in Down Syndrome-Implications for Clinical Trials and Treatments for All.
    Lemere CA; Head E; Holtzman DM
    JAMA Neurol; 2021 Aug; 78(8):913-915. PubMed ID: 34228117
    [No Abstract]   [Full Text] [Related]  

  • 2. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study.
    Saddiki H; Fayosse A; Cognat E; Sabia S; Engelborghs S; Wallon D; Alexopoulos P; Blennow K; Zetterberg H; Parnetti L; Zerr I; Hermann P; Gabelle A; Boada M; Orellana A; de Rojas I; Lilamand M; Bjerke M; Van Broeckhoven C; Farotti L; Salvadori N; Diehl-Schmid J; Grimmer T; Hourregue C; Dugravot A; Nicolas G; Laplanche JL; Lehmann S; Bouaziz-Amar E; ; Hugon J; Tzourio C; Singh-Manoux A; Paquet C; Dumurgier J
    PLoS Med; 2020 Aug; 17(8):e1003289. PubMed ID: 32817639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in CSF biomarkers vary by Alzheimer disease stage and
    Babapour Mofrad R; Tijms BM; Scheltens P; Barkhof F; van der Flier WM; Sikkes SAM; Teunissen CE
    Neurology; 2020 Oct; 95(17):e2378-e2388. PubMed ID: 32788242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aβ amyloid, cognition, and APOE genotype in healthy older adults.
    Lim YY; Ellis KA; Ames D; Darby D; Harrington K; Martins RN; Masters CL; Rowe C; Savage G; Szoeke C; Villemagne VL; Maruff P;
    Alzheimers Dement; 2013 Sep; 9(5):538-45. PubMed ID: 23159043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease.
    Mormino EC; Betensky RA; Hedden T; Schultz AP; Ward A; Huijbers W; Rentz DM; Johnson KA; Sperling RA; ; ;
    Neurology; 2014 May; 82(20):1760-7. PubMed ID: 24748674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E ɛ4, Cognitive Function, and Pain Experience in Down Syndrome: A Pilot Study.
    de Knegt NC; Schuengel C; Evenhuis HM; Lobbezoo F; Scherder EJ
    Arch Clin Neuropsychol; 2016 Aug; 31(5):389-400. PubMed ID: 27193365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
    McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP
    Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of family history and apolipoprotein E epsilon4 status on cognitive decline in the absence of Alzheimer dementia: the Cache County Study.
    Hayden KM; Zandi PP; West NA; Tschanz JT; Norton MC; Corcoran C; Breitner JC; Welsh-Bohmer KA;
    Arch Neurol; 2009 Nov; 66(11):1378-83. PubMed ID: 19901170
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Mirza SS; Saeed U; Knight J; Ramirez J; Stuss DT; Keith J; Nestor SM; Yu D; Swardfager W; Rogaeva E; St George Hyslop P; Black SE; Masellis M;
    Neurology; 2019 Nov; 93(19):e1807-e1819. PubMed ID: 31575706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of APOE genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer's disease.
    Kennedy RE; Cutter GR; Schneider LS
    Alzheimers Dement; 2014 May; 10(3):349-59. PubMed ID: 23712001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Apolipoprotein E ε4 With Transactive Response DNA-Binding Protein 43.
    Wennberg AM; Tosakulwong N; Lesnick TG; Murray ME; Whitwell JL; Liesinger AM; Petrucelli L; Boeve BF; Parisi JE; Knopman DS; Petersen RC; Dickson DW; Josephs KA
    JAMA Neurol; 2018 Nov; 75(11):1347-1354. PubMed ID: 30422173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease.
    Qian W; Fischer CE; Schweizer TA; Munoz DG
    Curr Alzheimer Res; 2018; 15(2):187-194. PubMed ID: 28847281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.
    Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT;
    Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment.
    Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
    J Korean Med Sci; 2016 Feb; 31(2):286-95. PubMed ID: 26839485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer disease: Joining the dots between APOE ε4 and late-onset Alzheimer disease via integrative genomics.
    Kingwell K
    Nat Rev Neurol; 2013 Sep; 9(9):483. PubMed ID: 23938735
    [No Abstract]   [Full Text] [Related]  

  • 17. Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease.
    Carmona-Iragui M; Balasa M; Benejam B; Alcolea D; Fernández S; Videla L; Sala I; Sánchez-Saudinós MB; Morenas-Rodriguez E; Ribosa-Nogué R; Illán-Gala I; Gonzalez-Ortiz S; Clarimón J; Schmitt F; Powell DK; Bosch B; Lladó A; Rafii MS; Head E; Molinuevo JL; Blesa R; Videla S; Lleó A; Sánchez-Valle R; Fortea J
    Alzheimers Dement; 2017 Nov; 13(11):1251-1260. PubMed ID: 28463681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When time's arrow doesn't bend: APOE-ε4 influences episodic memory before old age.
    Eich TS; Tsapanou A; Stern Y
    Neuropsychologia; 2019 Oct; 133():107180. PubMed ID: 31473197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E (APOE) ε4 and episodic memory decline in Alzheimer's disease: A review.
    El Haj M; Antoine P; Amouyel P; Lambert JC; Pasquier F; Kapogiannis D
    Ageing Res Rev; 2016 May; 27():15-22. PubMed ID: 26876367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep.
    Lim AS; Yu L; Kowgier M; Schneider JA; Buchman AS; Bennett DA
    JAMA Neurol; 2013 Dec; 70(12):1544-51. PubMed ID: 24145819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.